Somnodent vs Herbst in Mild and Moderate OSA Patients

NCT ID: NCT02724865

Last Updated: 2016-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

140 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-31

Study Completion Date

2018-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Obstructive sleep apnea (OSA) is a common chronic sleep disorder that often requires lifelong care. The prevalence in the Netherlands is estimated around 300.000 patients. Due to longer life expectancy and increase in weight in the general population, its prevalence is expected to rise. Patients with mild and moderate OSA are treated primarily with an oral appliance at present time. Different oral appliances are available, but most used is the mandibular advancement device (MAD). This study focuses on two different types of MAD: the classic Herbst appliance, which is attached to the mandible and the maxilla and has an iron bar to regulate the open space; and the Somnodent, which consists of two separate splints, fixed on the mandible and the maxilla, but has no iron bar attached.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oral appliance therapy; Somnodent®

Somnodent is a duobloc appliance, which is frequently used in OSA treatment and is titratable.

Group Type ACTIVE_COMPARATOR

Somnodent® (Oral appliance therapy)

Intervention Type DEVICE

Oral appliance therapy; Herbst®

Herbst is a duobloc appliance, which is frequently used in OSA treatment and is titratable.

Group Type ACTIVE_COMPARATOR

Herbst® (Oral appliance therapy)

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Somnodent® (Oral appliance therapy)

Intervention Type DEVICE

Herbst® (Oral appliance therapy)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years and older
* Ability to speak, read, and write Dutch.
* Ability to follow-up.
* Ability to use a computer with internet connection for online questionnaires.
* Diagnosis with symptomatic mild or moderate OSA (5 \< AHI \< 30).
* Expected to maintain current lifestyle (sports, medicine, diet, etc.)

Exclusion Criteria

* Untreated periodontal problems, dental pain, and a lack of retention possibilities for an MAD.
* Medication used/related to sleeping disorders.
* Evidence of respiratory/sleep disorders other than OSA (eg. central sleep apnea syndrome).
* Systemic disorders (based on medical history and examination; e.g. rheumatoid arthritis)
* Temporomandibular disorders (based on the function examination of the masticatory system).
* Medical history of known causes of tiredness by day, or severe sleep disruption (insomnia, Periodic Limb Movement Disorder, Narcolepsy).
* Known medical history of mental retardation, memory disorders, or psychiatric disorders.
* Reversible morphological upper airway abnormalities (e.g. enlarged tonsils). - Inability to provide informed consent.
* simultaneous use of other modalities to treat OSA.
* Previous treatment with a MAD.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Academic Centre for Dentistry in Amsterdam

OTHER

Sponsor Role collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

M.H.T. de Ruiter

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Academic Medical Center Amsterdam

Amsterdam, , Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Maurits de Ruiter, DDS

Role: CONTACT

0031205662300

Jan de Lange, MD, DDS, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Maurits de Ruiter, DMD

Role: primary

0031205662300

Jan de Lange, MD, DMD, PhD

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Young TB. Epidemiology of daytime sleepiness: definitions, symptomatology, and prevalence. J Clin Psychiatry. 2004;65 Suppl 16:12-6.

Reference Type BACKGROUND
PMID: 15575799 (View on PubMed)

Hoekema A, Stegenga B, De Bont LG. Efficacy and co-morbidity of oral appliances in the treatment of obstructive sleep apnea-hypopnea: a systematic review. Crit Rev Oral Biol Med. 2004 Jun 4;15(3):137-55. doi: 10.1177/154411130401500303.

Reference Type RESULT
PMID: 15187032 (View on PubMed)

Shi X, Lobbezoo F, Chen H, Rosenmoller BRAM, Berkhout E, de Lange J, Aarab G. Effects of mandibular advancement devices on upper airway dimensions in obstructive sleep apnea: responders versus non-responders. Clin Oral Investig. 2023 Sep;27(9):5649-5660. doi: 10.1007/s00784-023-05186-w. Epub 2023 Aug 17.

Reference Type DERIVED
PMID: 37589748 (View on PubMed)

Shi X, Lobbezoo F, Chen H, Rosenmoller BRAM, Berkhout E, de Lange J, Aarab G. Comparisons of the effects of two types of titratable mandibular advancement devices on respiratory parameters and upper airway dimensions in patients with obstructive sleep apnea: a randomized controlled trial. Clin Oral Investig. 2023 May;27(5):2013-2025. doi: 10.1007/s00784-023-04945-z. Epub 2023 Mar 17.

Reference Type DERIVED
PMID: 36928350 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NL44085.018.13

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.